Palmitoylethanolamide (Levagen+) for Menstrual Pain Relief
[vc_row css_animation="element_from_fade" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="center" background_image_as_pattern="without_pattern" padding_bottom="0" z_index="" css=".vc_custom_1533794039349{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}"][vc_column][vc_column_text css=""] Palmitoylethanolamide (Levagen+) for Menstrual Pain Relief Insights from a Recent Clinical Study [/vc_column_text][vc_row_inner row_type="row" type="grid" text_align="left" css_animation="" background_color="#ffffff" css=".vc_custom_1534244134279{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 60px !important;}"][vc_column_inner css=".vc_custom_1534244647194{margin-top: -10% !important;padding-right: 50px !important;padding-left: 50px !important;}"][vc_empty_space][vc_single_image image="73809" img_size="full" alignment="center" css=".vc_custom_1739507457774{padding-right: 10% !important;padding-left: 10% !important;}" qode_css_animation="" qode_hover_animation="zoom_in"][vc_empty_space height="20px"][vc_column_text css=""] Menstrual pain, or primary dysmenorrhea, represents a significant challenge for women worldwide, particularly those of reproductive age. Estimated to affect 45 to 95% of this population, dysmenorrhea often leads to impeded daily activities, work absenteeism, and a profound personal impact. Despite these...